Skip to main content
OpenTrials

Clinical trial condition

Atrial Flutter

Explore clinical trials studying Atrial Flutter. Study availability and eligibility vary by location and protocol.

157 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Atrial Flutter trial results

Completed

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

NCT00126061

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, +4 more
Locations
  • Site 26 Los Angeles, California, United States
  • Site 27 Santa Ana, California, United States
  • Site 24 Honolulu, Hawaii, United States
  • Site 25 Tullahoma, Tennessee, United States
View all 26 locations
View Trial Details
Completed

Pharmacogenetic Dosing of Warfarin

NCT02065388

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, +13 more
Locations
  • Kaohsiung Medical University Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • Chang Gung Memorial Hospital Taoyuan, Taiwan
View Trial Details
Completed

Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies

NCT01139814

Conditions
Arrhythmias, Cardiac, Atrial Flutter, Cardiac Conduction System Disease, +7 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Sequoia Hospital Redwood City, California, United States
  • Northwestern Medical Center Chicago, Illinois, United States
  • Genesis Health, Davenport, Iowa, United States
View Trial Details
Completed

Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter

NCT00233441

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, +4 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • sanofi-aventis Australia & New Zealand administrative office Macquarie Park, New South Wales, Australia
  • Sanofi-Aventis Administrative Office Laval, Canada
View all 17 locations
View Trial Details
Completed

Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr

NCT00232310

Conditions
Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, +4 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Laval, Canada
  • Sanofi-Aventis Administrative Office Prague, Czechia
  • Sanofi-Aventis Administrative Office Paris, France
View Trial Details

Related conditions